AstraZeneca to acquire Amolyt Pharma

Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition

Syngene biologics facility to be operational for US, European customers from mid-year

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

Cipla appoints Venkata Sai Mungara as Global Head – Supply Chain

Mungara has over 25+ years of experience in the supply chain domain

Sumitomo Pharma announces availability of ORGOVYX in Canada

The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer

Evonik Vland Biotech JV commences operations

Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China

Lupin receives Form 483 with 1 observation from USFDA after inspection at Aurangabad facility

The company is confident of addressing the concern raised by the USFDA

CuraTeQ Biologics announces the successful Phase 1 clinical study outcome of their BP11 product

Indranil Sen, CFO, Biocon resigned

Sen spent a decade with Biocon and held various key roles,

Abbott India appointed Swati Dalal as MD

Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager

Zydus receives USFDA final approval for chlorpromazine hydrochloride injection

Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders